
Sunland Pharma & Chemss Private Limited
Founded in 2015 and headquartered in Tamil Nadu, India.
Founded in 2015 and headquartered in Tamil Nadu, India.
Chennai, Tamil Nadu, India
+91-XXXXXXXXXX
-
U33110TN2015PTC101323
101323
Private Limited Indian Non-Government Company
08 Jul 2015
-
-
Unlisted
Roc Chennai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jeeva Balaraman ![]() | Director | 08-Jul-2015 | Current |
Srinivasan Sampath ![]() | Director | 13-Jul-2015 | Current |
Rajesh Ethirajan ![]() | Director | 08-Jul-2015 | Current |
Enhance accessibility to Sunland Pharma & Chemss's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Sunland Pharma & Chemss's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Jeeva Balaraman and Srinivasan Sampath are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sunland Pharma & Chemss, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sunland Pharma & Chemss, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunland Pharma & Chemss's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Srinivasan Sampath was appointed as a Director was appointed as a Director on 13 Jul 2015 & has been associated with this company since 9 years 7 months .
Jeeva Balaraman was appointed as a Director was appointed as a Director on 08 Jul 2015 & has been associated with this company since 9 years 7 months .
Rajesh Ethirajan was appointed as a Director was appointed as a Director on 08 Jul 2015 & has been associated with this company since 9 years 7 months .
Sunland Pharma & Chemss Private Limited was registered on 08 Jul 2015 with Roc Chennai & aged 9 years 7 months as per MCA records.
Sunland Pharma & Chemss Private Limited was incorporated on 08 Jul 2015.
The authorized share capital of Sunland Pharma & Chemss Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 3 directors are associated with Sunland Pharma & Chemss Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Sunland Pharma & Chemss Private Limited is Sudharsanam Tower No.6 & 8 Old No.176, Coral Merchant Street Mannady, Chennai, Tamil Nadu, India, 600001.
The corporate identification number (CIN) of Sunland Pharma & Chemss Private Limited is U33110TN2015PTC101323 and the company number is 101323 as per Ministry of Corporate Affairs (MCA).